Literature DB >> 8305816

"Neuroendocrine" differentiation in hepatocellular carcinomas (HCCs): immunohistochemical reactivity is related to distinct tumor cell types, but not to tumor grade.

M Zhao1, J A Laissue, A Zimmermann.   

Abstract

We have analyzed neuroendocrine differentiation (ND) in hepatocellular carcinomas (HCCs) of fifty patients. It turned out that ND is frequent in HCCs, and that it is not restricted to fibrolamellar hepatocellular carcinoma (FL-HCC). Multiexpression is seen in a quarter of the cases, and marker coexpression may occur within the same tumor cell. ND predominates in trabecular and mixed HCCs, but does not appear to be related to grade. Most positive cases showed a hepatocyte-like cell morphology, frequently associated with bile formation. It thus appears that the HCC cell type most likely to show ND is a hepatocyte-like one, i.e. differentiated cell, frequently polarized and producing bile, rather than a small and poorly-differentiated cell. Possible pathogenic mechanisms leading to ND in HCCs are briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8305816

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  10 in total

1.  Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature.

Authors:  Monica T Garcia; Pablo A Bejarano; Maria Yssa; Efren Buitrago; Alan Livingstone
Journal:  Virchows Arch       Date:  2006-08-01       Impact factor: 4.064

2.  Regulatory peptide receptors in human hepatocellular carcinomas.

Authors:  J C Reubi; A Zimmermann; S Jonas; B Waser; P Neuhaus; U Läderach; B Wiedenmann
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

3.  Chromogranin A-positive tumor cells in human esophageal squamous cell carcinomas.

Authors:  Aping Yuan; Jinzhong Liu; Yiqing Liu; Guanglin Cui
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

4.  Elevated serum levels of Chromogranin A in hepatocellular carcinoma.

Authors:  Antonio Biondi; Giulia Malaguarnera; Marco Vacante; Massimiliano Berretta; Velia D'Agata; Michele Malaguarnera; Francesco Basile; Filippo Drago; Gaetano Bertino
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

5.  Undifferentiated carcinoma of the liver: a case report with immunohistochemical analysis.

Authors:  Takashi Maeda; Hiroto Kayashima; Daisuke Imai; Kazuki Takeishi; Noboru Harada; Eiji Tsujita; Ayumi Matsuyama; Shinichi Tsutsui; Hiroyuki Matsuda
Journal:  Surg Case Rep       Date:  2017-01-10

6.  Hepatocellular Carcinoma and High Grade Neuroendocrine Carcinoma: A Case Report and Review of the Literature.

Authors:  El Mehdi Tazi; Ismail Essadi; Hind M'rabti; Hassan Errihani
Journal:  World J Oncol       Date:  2011-02-26

Review 7.  Re-Recognizing the Cellular Origin of the Primary Epithelial Tumors of the Liver.

Authors:  Jiliang Feng; Ruidong Zhu; Yu Yin; Shanshan Wang; Lei Zhou; Fudong Lv; Dawei Zhao
Journal:  J Hepatocell Carcinoma       Date:  2021-12-07

Review 8.  Fibrolamellar carcinoma: 2012 update.

Authors:  Michael Torbenson
Journal:  Scientifica (Cairo)       Date:  2012-09-23

9.  Pleomorphic neoplasm in a liver: A potential pitfall for misdiagnosis.

Authors:  Lubna Alattia; Kyle Molberg; Elena Lucas
Journal:  Cytojournal       Date:  2020-04-22       Impact factor: 2.091

10.  Incidental Collision Tumor of Hepatocellular Carcinoma and Neuroendocrine Carcinoma.

Authors:  Düriye Betül Yılmaz; Zeynep Bayramoğlu; Gülşah Ünay; Erdem Ayık; Cumhur İbrahim Başsorgun; Gülsüm Özlem Elpek
Journal:  J Clin Transl Hepatol       Date:  2018-06-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.